Patent Term Extension Application for AGAMREE® (vamorolone), Patent No. 8,334,279

Documents

Comments

Key Dates

Comment Period OpensJan 26, 2024

Comment Period ClosesAug 26, 2025

Type	Title	Posted	Comments	Status
Other	Letter to U. S. Patent and Trademark Office	Jul 31, 2026	--

CDER

Catalyst Pharmaceuticals, Inc.

Sterne, Kessler, Goldstein and Fox PLLC

Patent Term Extension Application

for AGAMREE® (vamorolone)

Patent No. 8,334,279

OPEN